ResearcherUniversity of NebraskaNo recent work listed
Jean L Grem
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 0
- Pancreatic cancer trials
- 3 (principal investigator on 2)
- Pancreatic cancer grants
- 0
- Collaborators
- 0
2004: 1 trial · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 trial
Trials 3
- FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer Principal investigator NCT04141995↗
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer Principal investigator NCT01825603↗
- Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Study chair NCT00089024↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.